Neil Chatterji
Stock Analyst at B. Riley Securities
(0.78)
# 2352
Out of 5,372 analysts
26
Total ratings
38.46%
Success rate
9.37%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro | Maintains: Strong Buy | 20 28 | 11.5 | 143.48% | 4 | Apr 25, 2025 | |
OPRX OptimizeRx | Maintains: Buy | 17 13 | 13.73 | -5.32% | 3 | Dec 24, 2024 | |
AUGX Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
ESTA Establishment Labs H... | Maintains: Buy | 95 50 | 36.69 | 36.28% | 2 | Nov 9, 2023 | |
SILK Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 | 1.25 | 500% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 12.44 | 44.69% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 3.23 | 39.32% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 0.72 | 386.11% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2.28 | 141.23% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.27 | 318.5% | 1 | Oct 4, 2022 |